首页> 美国卫生研究院文献>Journal of Lipid Research >Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions
【2h】

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

机译:在富含脂质的条件下载脂蛋白C-III在McA-RH7777细胞中的表达增强了VLDL的组装和分泌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Apolipoprotein (apo) C-III plays a regulatory role in VLDL lipolysis and clearance. In this study, we determined a potential intracellular role of apoC-III in hepatic VLDL assembly and secretion. Stable expression of recombinant apoC-III in McA-RH7777 cells resulted in increased secretion efficiency of VLDL-associated triacylglycerol (TAG) and apoB-100 in a gene-dosage-dependent manner. The stimulatory effect of apoC-III on TAG secretion was manifested only when cells were cultured under lipid-rich (i.e., media supplemented with exogenous oleate) but not lipid-poor conditions. The stimulated TAG secretion was accompanied by increased secretion of apoB-100 and apoB-48 as VLDL1. Expression of apoC-III also increased mRNA and activity of microsomal triglyceride transfer protein (MTP). Pulse-chase experiments showed that apoC-III expression promoted VLDL1 secretion even under conditions where the MTP activity was inhibited immediately after the formation of lipid-poor apoB-100 particles, suggesting an involvement of apoC-III in the second-step VLDL assembly process. Consistent with this notion, the newly synthesized apoC-III was predominantly associated with TAG within the microsomal lumen that resembled lipid precursors of VLDL. Introducing an Ala23-to-Thr mutation into apoC-III, a naturally occurring mutation originally identified in two Mayan Indian subjects with hypotriglyceridemia, abolished the ability of apoC-III to stimulate VLDL secretion from transfected cells. Thus, expression of apoC-III in McA-RH7777 cells enhances hepatic TAG-rich VLDL assembly and secretion under lipid-rich conditions.
机译:载脂蛋白(apo)C-III在VLDL脂解和清除中起调节作用。在这项研究中,我们确定了apoC-III在肝VLDL组装和分泌中的潜在细胞内作用。重组apoC-III在McA-RH7777细胞中的稳定表达导致VLDL相关的三酰基甘油(TAG)和apoB-100的分泌效率以基因剂量依赖性方式增加。仅当细胞在富含脂质的条件下(即补充有外源油酸酯的培养基)培养细胞,而在缺乏脂质的条件下才显示apoC-III对TAG分泌的刺激作用。刺激的TAG分泌伴随着作为VLDL1的apoB-100和apoB-48的分泌增加。 apoC-III的表达也增加了微粒体甘油三酸酯转移蛋白(MTP)的mRNA和活性。脉冲追踪实验表明,即使在脂质贫乏的apoB-100颗粒形成后立即抑制MTP活性的条件下,apoC-III的表达仍能促进VLDL1的分泌,这表明apoC-III参与了第二步VLDL组装过程。与此概念一致,新合成的apoC-III主要与微粒体腔内的TAG相关,类似于VLDL的脂质前体。将Ala23到Thr突变引入apoC-III,这是一种自然发生的突变,最初是在两名患有低甘油三酸酯血症的玛雅印第安人受试者中发现的,消除了apoC-III刺激转染细胞中VLDL分泌的能力。因此,ApoC-III在McA-RH7777细胞中的表达增强了富含脂质的肝脏TAG的VLDL装配和分泌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号